MDIC Announces Pathology ‘Collaborative Community’ With FDA Involvement
This is MDIC’s third collaborative community, following groups for the US FDA’s Case for Quality and health technology.
You may also be interested in...
The US agency is participating in collaborative communities centered around eye health and the development of real-world evidence, representing the first two of what the agency hopes will be at least 10 communities by the end of 2020.
The updates reflect changes to standards on medical electrical equipment and a wide range of device types.
The sentences are the latest chapter in a long-running off-label marketing case.